9.8 |
29.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
5.4 |
16.1 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
5.1 |
25.6 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
5.0 |
45.2 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
4.8 |
28.5 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
4.2 |
12.7 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
3.6 |
10.8 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
3.5 |
27.9 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.2 |
41.0 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
3.0 |
15.1 |
GO:2000302 |
positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.9 |
8.8 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
2.8 |
11.4 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
2.8 |
14.1 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
2.7 |
24.3 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
2.7 |
13.3 |
GO:0042701 |
progesterone secretion(GO:0042701) |
2.5 |
28.0 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
2.5 |
12.6 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
2.5 |
15.0 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
2.4 |
38.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.4 |
9.5 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
2.3 |
16.1 |
GO:0019532 |
oxalate transport(GO:0019532) |
2.2 |
27.0 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
2.2 |
8.9 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
2.2 |
10.9 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
2.1 |
6.4 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
2.1 |
8.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.1 |
12.7 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
2.1 |
27.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
1.9 |
27.0 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
1.8 |
7.4 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
1.8 |
12.8 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
1.8 |
5.5 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.7 |
5.1 |
GO:0038095 |
positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
1.7 |
15.0 |
GO:0098907 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
1.7 |
21.5 |
GO:0097090 |
presynaptic membrane organization(GO:0097090) |
1.5 |
7.7 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
1.5 |
4.6 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
1.5 |
4.6 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
1.5 |
7.6 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.5 |
4.6 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) noradrenergic neuron differentiation(GO:0003357) |
1.5 |
4.5 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
1.5 |
7.5 |
GO:0086018 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.5 |
5.9 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
1.5 |
32.2 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.4 |
9.9 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.3 |
4.0 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
1.3 |
56.4 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
1.3 |
46.5 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
1.3 |
6.3 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.2 |
3.7 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
1.2 |
3.7 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
1.2 |
4.8 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
1.2 |
2.4 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
1.2 |
11.7 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.1 |
2.2 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
1.1 |
10.5 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
1.0 |
4.2 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
1.0 |
3.1 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
1.0 |
5.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
1.0 |
32.5 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
1.0 |
8.0 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.0 |
11.8 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.0 |
3.9 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
1.0 |
5.8 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
1.0 |
6.8 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
1.0 |
6.8 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
1.0 |
2.9 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
1.0 |
30.6 |
GO:0060074 |
synapse maturation(GO:0060074) |
1.0 |
1.9 |
GO:0061349 |
cardiac right atrium morphogenesis(GO:0003213) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) |
0.9 |
13.1 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.9 |
13.8 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
0.9 |
5.5 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
0.9 |
4.5 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
0.9 |
4.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.8 |
5.1 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
0.8 |
3.4 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.8 |
5.7 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.8 |
0.8 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
0.8 |
2.4 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.8 |
5.6 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
0.8 |
2.4 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.8 |
1.6 |
GO:2000481 |
positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.8 |
6.3 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
0.8 |
1.6 |
GO:1904395 |
retinal rod cell differentiation(GO:0060221) positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.8 |
2.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
0.8 |
3.0 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
0.8 |
6.1 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.7 |
9.0 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.7 |
4.4 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
0.7 |
7.9 |
GO:1903421 |
regulation of synaptic vesicle recycling(GO:1903421) |
0.7 |
1.4 |
GO:0060283 |
negative regulation of oocyte development(GO:0060283) |
0.7 |
9.4 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.7 |
1.4 |
GO:1904139 |
microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.7 |
1.4 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.7 |
7.7 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
0.7 |
8.9 |
GO:0001553 |
luteinization(GO:0001553) |
0.7 |
4.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 |
2.0 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.7 |
1.3 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
0.7 |
9.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
0.7 |
2.0 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
0.6 |
1.3 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 |
3.2 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 |
3.8 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.6 |
3.2 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
0.6 |
1.9 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.6 |
6.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
0.6 |
9.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.6 |
2.4 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.6 |
3.0 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
0.6 |
9.3 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
0.6 |
2.9 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.6 |
13.2 |
GO:0007097 |
nuclear migration(GO:0007097) |
0.6 |
8.6 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
0.6 |
2.2 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.6 |
9.5 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
0.6 |
2.2 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
0.5 |
2.2 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.5 |
8.8 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
0.5 |
2.1 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 |
1.6 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.5 |
7.4 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
0.5 |
2.1 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
0.5 |
1.5 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
0.5 |
1.5 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.5 |
1.0 |
GO:2000822 |
regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.5 |
2.5 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
0.5 |
17.2 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 |
2.0 |
GO:0033762 |
response to glucagon(GO:0033762) |
0.5 |
2.5 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.5 |
1.5 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
0.5 |
19.4 |
GO:0034605 |
cellular response to heat(GO:0034605) |
0.5 |
8.6 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.5 |
0.5 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
0.5 |
3.2 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
0.4 |
2.2 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
0.4 |
1.3 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
0.4 |
2.6 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
0.4 |
0.4 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
0.4 |
0.9 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
0.4 |
1.7 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.4 |
2.5 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.4 |
2.5 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 |
1.6 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
0.4 |
2.5 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
0.4 |
8.2 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 |
9.3 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 |
0.8 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
0.4 |
1.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
0.4 |
1.1 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.4 |
0.8 |
GO:0051026 |
chiasma assembly(GO:0051026) |
0.4 |
4.9 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
0.4 |
3.8 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
0.4 |
4.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 |
3.0 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 |
1.5 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
0.4 |
1.4 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
0.4 |
1.1 |
GO:0051934 |
positive regulation of neurotransmitter uptake(GO:0051582) dopamine uptake involved in synaptic transmission(GO:0051583) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) catecholamine uptake involved in synaptic transmission(GO:0051934) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.4 |
2.9 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
0.4 |
1.4 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
0.4 |
1.1 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
0.3 |
2.1 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
0.3 |
1.7 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 |
4.1 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
0.3 |
1.4 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.3 |
7.3 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
0.3 |
1.3 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
0.3 |
0.7 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.3 |
0.7 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
0.3 |
16.9 |
GO:0021766 |
hippocampus development(GO:0021766) |
0.3 |
2.9 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 |
0.6 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
0.3 |
22.3 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 |
2.8 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
0.3 |
1.6 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
0.3 |
2.2 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
0.3 |
2.4 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 |
1.2 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
0.3 |
7.0 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
0.3 |
12.8 |
GO:0008542 |
visual learning(GO:0008542) |
0.3 |
0.9 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
0.3 |
6.6 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 |
4.5 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 |
0.6 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
0.3 |
0.6 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
0.3 |
3.3 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
0.3 |
1.1 |
GO:0060353 |
regulation of cell adhesion molecule production(GO:0060353) |
0.3 |
8.2 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
0.3 |
3.7 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
0.3 |
1.3 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 |
1.3 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
0.3 |
0.5 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.3 |
0.3 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
0.2 |
19.0 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
0.2 |
1.5 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
0.2 |
39.1 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
0.2 |
3.2 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
0.2 |
3.7 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.2 |
0.5 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
0.2 |
1.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 |
0.9 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
0.2 |
0.9 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 |
7.1 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
0.2 |
1.1 |
GO:0021592 |
fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
0.2 |
0.2 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 |
1.5 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
0.2 |
1.1 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
0.2 |
2.1 |
GO:0048670 |
regulation of collateral sprouting(GO:0048670) |
0.2 |
1.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.2 |
0.4 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
0.2 |
1.6 |
GO:0060613 |
fat pad development(GO:0060613) |
0.2 |
2.0 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
0.2 |
1.0 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) |
0.2 |
0.6 |
GO:2000343 |
positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 |
2.4 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
0.2 |
0.6 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 |
1.0 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 |
2.5 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
0.2 |
1.3 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
0.2 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
0.2 |
0.9 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 |
1.8 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 |
1.2 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 |
0.9 |
GO:0030242 |
pexophagy(GO:0030242) |
0.2 |
5.3 |
GO:1902667 |
regulation of axon guidance(GO:1902667) |
0.2 |
0.2 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 |
0.2 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.2 |
0.5 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 |
1.1 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
0.2 |
2.7 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 |
1.0 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.2 |
1.7 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
0.2 |
0.8 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
0.2 |
1.4 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
0.2 |
1.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
0.2 |
0.3 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 |
1.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
0.2 |
0.6 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 |
0.4 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 |
1.5 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
0.1 |
1.0 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 |
1.5 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
0.1 |
2.0 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
0.1 |
3.3 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
0.1 |
1.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
0.1 |
1.1 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 |
1.0 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 |
0.4 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
0.1 |
0.6 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 |
1.9 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
0.1 |
0.3 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 |
0.5 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
0.1 |
0.5 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
0.1 |
1.5 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
0.1 |
0.7 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
0.1 |
1.2 |
GO:0071625 |
vocalization behavior(GO:0071625) |
0.1 |
0.8 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 |
0.9 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 |
8.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
0.1 |
4.2 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
0.1 |
0.3 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 |
1.4 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
0.1 |
2.5 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 |
2.1 |
GO:0051693 |
actin filament capping(GO:0051693) |
0.1 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
0.1 |
1.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
0.1 |
0.7 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 |
1.4 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
0.1 |
1.5 |
GO:0001783 |
B cell apoptotic process(GO:0001783) |
0.1 |
1.0 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
0.1 |
2.9 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
0.1 |
0.4 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.1 |
1.8 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 |
1.1 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
0.1 |
1.9 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
0.1 |
0.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 |
0.8 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 |
0.6 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
0.1 |
0.8 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 |
0.3 |
GO:1903722 |
negative regulation of centriole replication(GO:0046600) regulation of centriole elongation(GO:1903722) |
0.1 |
0.2 |
GO:1901419 |
vitamin D receptor signaling pathway(GO:0070561) regulation of vitamin D receptor signaling pathway(GO:0070562) cellular response to vitamin(GO:0071295) cellular response to vitamin D(GO:0071305) regulation of response to alcohol(GO:1901419) |
0.1 |
0.8 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 |
1.4 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 |
0.3 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 |
0.2 |
GO:0032930 |
positive regulation of superoxide anion generation(GO:0032930) |
0.1 |
0.2 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
0.1 |
7.8 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 |
2.4 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
0.1 |
0.6 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 |
0.5 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
0.1 |
0.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 |
1.3 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
0.1 |
0.7 |
GO:0006828 |
manganese ion transport(GO:0006828) |
0.1 |
1.1 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
0.1 |
0.4 |
GO:0030035 |
microspike assembly(GO:0030035) |
0.1 |
0.9 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
0.1 |
1.8 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 |
1.7 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 |
0.4 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 |
3.8 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
0.1 |
0.4 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 |
0.5 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.1 |
0.9 |
GO:0017144 |
drug metabolic process(GO:0017144) |
0.1 |
0.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
0.1 |
0.5 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
0.1 |
0.4 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
0.1 |
2.1 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 |
1.4 |
GO:0007340 |
acrosome reaction(GO:0007340) |
0.1 |
0.3 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 |
0.4 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
0.1 |
0.4 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 |
1.3 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 |
0.5 |
GO:1902624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.1 |
0.2 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
0.1 |
1.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
0.1 |
6.9 |
GO:0098792 |
xenophagy(GO:0098792) |
0.1 |
0.5 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
0.1 |
0.4 |
GO:0097186 |
amelogenesis(GO:0097186) |
0.1 |
1.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 |
1.3 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
0.1 |
0.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
0.1 |
1.0 |
GO:0032402 |
melanosome transport(GO:0032402) |
0.1 |
0.6 |
GO:0007616 |
long-term memory(GO:0007616) |
0.1 |
4.3 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
0.1 |
0.4 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
0.1 |
1.3 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
0.1 |
1.2 |
GO:0002931 |
response to ischemia(GO:0002931) |
0.1 |
0.1 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
0.1 |
2.4 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
0.1 |
1.0 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
0.1 |
0.4 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
0.1 |
0.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 |
0.2 |
GO:0097154 |
GABAergic neuron differentiation(GO:0097154) |
0.1 |
1.9 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
0.1 |
3.4 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 |
0.4 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 |
0.5 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 |
1.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 |
1.3 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 |
0.8 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
0.1 |
1.4 |
GO:0006906 |
vesicle fusion(GO:0006906) |
0.1 |
0.3 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
0.1 |
3.7 |
GO:0050770 |
regulation of axonogenesis(GO:0050770) |
0.1 |
0.1 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
0.1 |
0.3 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.1 |
0.4 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
0.1 |
0.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 |
6.2 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
0.0 |
0.4 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
0.0 |
0.4 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 |
0.3 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 |
2.6 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
0.0 |
0.3 |
GO:0031424 |
keratinization(GO:0031424) |
0.0 |
0.3 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
0.0 |
1.2 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
0.0 |
0.1 |
GO:1903008 |
organelle disassembly(GO:1903008) |
0.0 |
0.4 |
GO:0032094 |
response to activity(GO:0014823) response to food(GO:0032094) |
0.0 |
0.5 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 |
0.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 |
0.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
0.0 |
0.4 |
GO:0021799 |
cerebral cortex radially oriented cell migration(GO:0021799) |
0.0 |
0.8 |
GO:0006491 |
N-glycan processing(GO:0006491) |
0.0 |
0.5 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
0.0 |
0.5 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
0.0 |
0.1 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
0.0 |
0.4 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
0.0 |
0.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
0.0 |
1.1 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 |
0.4 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 |
0.4 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 |
0.2 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 |
0.2 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
0.0 |
0.6 |
GO:0030325 |
adrenal gland development(GO:0030325) |
0.0 |
0.2 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.0 |
2.8 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
0.0 |
1.4 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
0.0 |
2.4 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
0.0 |
0.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 |
0.3 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
0.0 |
2.5 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
0.0 |
0.3 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 |
0.5 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
0.0 |
1.2 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
0.0 |
0.1 |
GO:0072488 |
nitrogen utilization(GO:0019740) ammonium transmembrane transport(GO:0072488) |
0.0 |
0.6 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
0.0 |
0.3 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 |
0.7 |
GO:0035690 |
cellular response to drug(GO:0035690) |
0.0 |
0.5 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
0.0 |
0.1 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
0.0 |
0.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
0.0 |
0.2 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 |
0.1 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
0.0 |
0.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
0.0 |
0.0 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
0.0 |
0.0 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
0.0 |
0.3 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
0.0 |
0.1 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
0.0 |
0.2 |
GO:0070131 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) positive regulation of mitochondrial translation(GO:0070131) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 |
0.2 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
0.0 |
0.1 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
0.0 |
0.2 |
GO:0034063 |
stress granule assembly(GO:0034063) |
0.0 |
0.7 |
GO:0016575 |
histone deacetylation(GO:0016575) |
0.0 |
0.6 |
GO:0006306 |
DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 |
0.1 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
0.0 |
0.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
0.0 |
0.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |